Andong Huang's most recent trade in Outlook Therapeutics Inc was a trade of 56,636 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Oct. 1, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Outlook Therapeutics Inc | Andong Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 56,636 | 56,636 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Andong Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 23,509 | 23,509 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Andong Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 10,984 | 10,984 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Andong Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 94,441 | 94,441 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Andong Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 41,065 | 41,065 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Andong Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2022 | 38,399 | 38,399 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Andong Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2022 | 21,878 | 21,878 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Andong Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2021 | 22,950 | 22,950 | - | - | Stock Option (Right to Buy) | |
| Outlook Therapeutics Inc | Andong Huang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2021 | 20,873 | 20,873 | - | - | Stock Option (Right to Buy) |